Invention Grant
- Patent Title: Glucagon and GLP-1 co-agonists for the treatment of obesity
-
Application No.: US16083064Application Date: 2017-03-10
-
Publication No.: US10676517B2Publication Date: 2020-06-09
- Inventor: Maria Aleksandra Bednarek , Lutz Ulrich Jermutus , Philip Ambery , Marcella Petrone
- Applicant: MEDIMMUNE LIMITED
- Applicant Address: GB Cambridge
- Assignee: MEDIMMUNE LIMITED
- Current Assignee: MEDIMMUNE LIMITED
- Current Assignee Address: GB Cambridge
- International Application: PCT/EP2017/055679 WO 20170310
- International Announcement: WO2017/153575 WO 20170914
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/605 ; A61P1/16 ; A61P3/04 ; A61K9/00 ; A61K38/00
Abstract:
Provided herein are methods of preventing and treating obesity and diabetes in patients comprising administering GLP-1/glucagon agonists peptides.
Public/Granted literature
- US20190185537A1 GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY Public/Granted day:2019-06-20
Information query
IPC分类:
